v3.26.1
Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 29, 2026
Mar. 30, 2025
EPS Numerator    
Income from continuing operations attributable to Pfizer Inc. common shareholders $ 2,701 $ 2,967
Income from continuing operations attributable to Pfizer Inc. common shareholders 2,701 2,967
Discontinued operations––net of tax (13) 0
Net income attributable to Pfizer Inc. common shareholders 2,687 2,967
Net income attributable to Pfizer Inc. common shareholders $ 2,687 $ 2,967
EPS Denominator    
Weighted-average number of common shares outstanding––Basic (in shares) 5,691 5,675
Common-share equivalents (in shares) 40 36
Weighted-average number of common shares outstanding––Diluted (in shares) 5,731 5,710
Anti-dilutive common stock equivalents (in shares) [1] 11 17
[1] These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.